Stocks and Investing
Stocks and Investing
Thu, August 5, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jayson Bedford Maintained (TNDM) at Buy with Increased Target to $120 on, Aug 5th, 2021
Jayson Bedford of Raymond James, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Increased Target from $115 to $120 on, Aug 5th, 2021.
Jayson has made no other calls on TNDM in the last 4 months.
There is 1 other peer that has a rating on TNDM. Out of the 1 peers that are also analyzing TNDM, 0 agree with Jayson's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jayson
- Travis Steed of "Barclays" Initiated at Sell and Held Target at $90 on, Tuesday, May 25th, 2021
Contributing Sources